NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
NASDAQ TRADE HALT CONTINUES GHRS.O REASON NOT AVAILABLE AT 04:00 AM
Recent news on GH Research
See all newsCorrected: UPDATE 2-Experts urge FDA to set clear safety and access standards for psychedelic drugs (September 14)
FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers pace
Ireland's GH Research Q2 net loss widens on higher R&D costs
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Street View: Psychedelic sector gains after report Lilly nears AtaiBeckley acquisition